Hepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCV
Open Access
- 15 July 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 198 (2) , 203-212
- https://doi.org/10.1086/589510
Abstract
Background. Injection drug users (IDUs) who successfully clear hepatitis C virus (HCV) have a reduced risk of developing chronic reinfection, despiteKeywords
This publication has 47 references indexed in Scilit:
- Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis CProceedings of the National Academy of Sciences, 2007
- Efficiency of the Ortho VITROS Assay for Detection of Hepatitis C Virus-Specific Antibodies Increased by Elimination of Supplemental Testing of Samples with Very Low Sample-to-Cutoff RatiosJournal of Clinical Microbiology, 2005
- Immunology of hepatitis B virus and hepatitis C virus infectionNature Reviews Immunology, 2005
- Long-term follow-up after successful interferon therapy of acute hepatitis CHepatology, 2004
- Effects of antiviral therapy on the cellular immune response in acute hepatitis CHepatology, 2004
- HCV Persistence and Immune Evasion in the Absence of Memory T Cell HelpScience, 2003
- Seroprevalence of Human Herpesvirus 8 among Injection Drug Users in San FranciscoThe Journal of Infectious Diseases, 2003
- Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCVJournal of Virology, 2001
- Lymphocyte Reactivity to Hepatitis C Virus (HCV) Antigens Shows Evidence for Exposure to HCV in HCV‐Seronegative Spouses of HCV‐Infected PatientsThe Journal of Infectious Diseases, 1997
- Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in AmsterdamAIDS, 1988